International Registry of Isolated Angioedema

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

Angioedema is a disease characterized by the appearance of self-limiting edema that last 1-5 days and affect the subcutaneous tissue and/or gastrointestinal and oropharyngeal mucosa. In this last location edema can be lethal causing asphyxia, in all other cases full recovery is complete. Attacks can appear as part of the syndrome urticaria angioedema and can be of allergic origin. But there is a group of non-allergic angioedema that occur without hives and can be either hereditary or acquired. These angioedema are identified in some cases on the basis of etiology, in others are identified by the mediator and an overall classification of these forms of angioedema was published in 2014 as a result of a consent conference organized by the proponents of this registry. Being these forms of angioedema rare, there are not significative case studies inclusive of a high number of patients. This registry aims to collect in a single place a high number of subjects with recurring angioedema and without urticaria.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Any patient with isolated angioedema without associated wheals.

• Patients with hereditary angioedema with or without C1 deficiency.

• Major patient with consent (signature)

• Minor patient whose parents / legal guardians have given their consent (signature)

Locations
Other Locations
France
University Hospital Grenoble
RECRUITING
Grenoble
Contact Information
Primary
laurence bouilelt, MD, PhD
lbouillet@chu-grenoble.fr
+33476765565
Backup
Isabelle Boccon-Gibod
iboccon-gibod@chu-grenoble.fr
+3347676767640
Time Frame
Start Date: 2018-09-01
Estimated Completion Date: 2028-09-01
Participants
Target number of participants: 1000
Treatments
Hereditary angioedema type I/II
Hereditary angioedema with C1Inh deficiency
Acquired angioedema
Angioedema with acquired C1Inh deficiency
Drug induced angioedema
Angioedema associated with ACEi used
Mast cell induced angioedema
Spontaneous mast cell induced isolated angioedema
Hereditary angioedema with nC1Inh
Hereditary angioedema with normal C1Inh and with F12, PLG, ANGPT2 mutations
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Grenoble

This content was sourced from clinicaltrials.gov